This is a community-generated profile. If you would like to claim it, please .
Manus Biosynthesis Funding
$32.4M
11 round
Startup Leadership Program
Manus Biosynthesis is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $32.4M. Their most recent funding was raised on November 26, 2024.
Funding Rounds
S
$32400000Investors of Manus Biosynthesis
Liebenthal Ventures
Early Stage and Angel Investing
Andy is an entrepreneur and active Angel Investor. He currently serves as an Entrepreneur-in-Residence at IESE Business School in Barcelona, Spain.
Partner at 650
Robert Chung
Portfolio manager and asset allocator for family offices and ultra-high-net-worth individuals and institutions
Civilization.VC is focused on synthetic biology + exponential health tech (genomics, diagnostics, digital health, AI, personalized + regenerative medicine).
Seasoned Entrepreneur with experience as a venture investor and recipient. Passion for Environmental and Social Impact Investing.
Currently the Deputy CIO for the most active VC in the US. Previously led finance & operations for a VC-backed startup, raising $40M+ in Series A-C funding
Nina Flax
Partner at Mayer Brown, Duke University, Harvard Law.
Abhijeet Birewar
Please refer my LinkedIn profile